Serum estrogen levels and prostate cancer risk in the prostate cancer prevention trial: a nested case-control study.

Publication Type:

Journal Article

Source:

Cancer causes & control : CCC, Volume 22, Issue 8, p.1121-31 (2011)

Keywords:

2011, Center-Authored Paper, Public Health Sciences Division, September 2011

Abstract:

Finasteride reduces prostate cancer risk by blocking the conversion of testosterone to dihydrotestosterone. However, whether finasteride affects estrogens levels or change in estrogens affects prostate cancer risk is unknown.